Found: 7
Select item for more details and to access through your institution.
Phase II study of Disulfiram and Cisplatin in Refractory Germ Cell Tumors. The GCT-SK-006 phase II trial.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 5, p. 1080, doi. 10.1007/s10637-022-01271-1
- By:
- Publication type:
- Article
Gemcitabine, carboplatin and veliparib in multiple relapsed/refractory germ cell tumours: The GCT-SK-004 phase II trial.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 6, p. 1664, doi. 10.1007/s10637-021-01130-5
- By:
- Publication type:
- Article
Phase II study of avelumab in multiple relapsed/refractory germ cell cancer.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 4, p. 748, doi. 10.1007/s10637-019-00805-4
- By:
- Publication type:
- Article
Long-term sexual functioning in germ-cell tumor survivors.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Diagnostic Challenges and Extraordinary Treatment Response in Rare Malignant PEComa Tumor of the Kidney.
- Published in:
- Journal of the Czech & Slovak Societies for Oncology / Klinická Onkologie, 2018, v. 31, n. 6, p. 448, doi. 10.14735/amko2018448
- By:
- Publication type:
- Article
The First Slovak Experience with Second-line Vinflunine in Advanced Urothelial Carcinomas.
- Published in:
- Journal of the Czech & Slovak Societies for Oncology / Klinická Onkologie, 2014, v. 27, n. 6, p. 429, doi. 10.14735/amko2014429
- By:
- Publication type:
- Article
Adenocarcinoma of the Rete Testis - a Rare Case of Testicular Malignancy.
- Published in:
- Journal of the Czech & Slovak Societies for Oncology / Klinická Onkologie, 2014, v. 27, n. 2, p. 136, doi. 10.14735/amko2014136
- By:
- Publication type:
- Article